Abizer Gaslightwala - 17 Jun 2025 Form 4 Insider Report for Akari Therapeutics Plc (AKTX)

Role
President & CEO, Director
Signature
/s/ Torsten Hombeck, as Attorney-in-Fact
Issuer symbol
AKTX
Transactions as of
17 Jun 2025
Net transactions value
+$18,000
Form type
4
Filing time
20 Jun 2025, 16:05:04 UTC
Previous filing
16 Jun 2025
Next filing
24 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Gaslightwala Abizer President & CEO, Director C/O AKARI THERAPEUTICS PLC, 22 BOSTON WHARF ROAD FL 7, BOSTON /s/ Torsten Hombeck, as Attorney-in-Fact 20 Jun 2025 0002049375

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKTX American Depositary Shares representing Ordinary Shares Purchase $18,000 +15,000 +6.1% $1.20 261,428 17 Jun 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.